Comments
Commented by Stefan Feulner on December 27th, 2022 | 06:04 CET
FuelCell Energy, Almonty Industries, SFC Energy - Fatal effects
Even now, commodity prices, which have risen exorbitantly in recent years, are correcting due to fears of a prolonged recession. In the long term, the super-cycles in critical raw materials needed for the energy transition and innovative technologies will likely continue. That is because there is already a threat of supply bottlenecks for the required industrial metals. For investors, this scenario offers a unique opportunity.
Read
Commented by Juliane Zielonka on December 23rd, 2022 | 08:00 CET
BioNxt Solutions, MorphoSys, BioNTech - Innovations and scaling potential for the portfolio
Around the world, patients are used to swallowing medicines in pill form. Sales of oral, fixed-dose drugs alone accounted for a whopping 23.8% of the global pharmaceutical drug delivery market in 2021. That is reason enough for Canadian biotech company BioNxt Solutions to further expand its strategic pole position. BioNxt Solutions secures further rights to a unique platform technology in this segment. Caution is currently the order of the day for MorphoSys. Analysts downgrade the target price from EUR 16 to EUR 12 after a disappointing Q3. BioNTech, on the other hand, can expand its dominance. The Mainz-based company is scaling up in the Asia-Pacific region with new production sites.
Read
Commented by André Will-Laudien on December 23rd, 2022 | 07:55 CET
Is the e-mobility gold rush coming to an end? Volkswagen, BYD, Alerio Gold, Deutsche Bank - What is going on with Tesla?
Elon Musk had a calculated fortune of around USD 280 billion at the peak of the Tesla share. After the crash of the miracle share and the purchase of Twitter, he is now said to own around USD 150 billion less. According to calculations by the analysis firm Factset, Musk still holds around 14% of the shares in electric car manufacturer Tesla. Here alone, there is a gaping loss of over USD 100 billion. New at the world's top for the first time is a Frenchman: Bernard Arnault, the 73-year-old CEO and co-owner of the luxury group LVMH. According to the US magazine Forbes, he has a total fortune of USD 186 billion - and thus passes Musk and Buffet. Has the "climate wonder weapon" electromobility already seen its horizon?
Read
Commented by Juliane Zielonka on December 22nd, 2022 | 16:09 CET
Almonty Industries, Rheinmetall, Apple - Asia and Africa push business
Almonty Industries is creating the first underground LTE security network for mine workers and production equipment in cooperation with Korea Telecom. The technology will enable work at the Sangdong Mine to proceed more safely and quickly. Tungsten is used in smartphones and other applications. As one of the largest smartphone producers, Apple is expanding its business in India. 5% of iPhone production is to be handled from there. This is a consequence of the lockdown experience with China. Armaments giant Rheinmetall, on the other hand, is enjoying an order from South Africa.
Read
Commented by Stefan Feulner on December 22nd, 2022 | 15:35 CET
Saturn Oil + Gas, BP, First Hydrogen - Potential recognized
The high volatility on the stock markets is likely to continue in the coming year, as the economic and geopolitical situation is too uncertain. This, in turn, offers enormous opportunities to acquire promising stocks at discounted levels that have received little attention from the public. With the ongoing correction in the oil sector, which major analyst firms believe is likely to regain strength in the US in the coming year, there are attractive companies, particularly from the second tier, that should significantly outperform the broader market in the expected upturn.
Read
Commented by Stefan Feulner on December 22nd, 2022 | 11:21 CET
Barrick Gold, Desert Gold, Iamgold - Takeovers on the rise
The record year 2020, with highs of over USD 2,070 per troy ounce at the base price, filled the coffers of the large gold producers. Due to the correction that has been going on for 2 years, smaller and mid-sized mining companies lost more than 80% of their value, making them attractive takeover targets at a cheaper level. Recently, there has been an increase in acquisitions, which are likely to increase further in the coming months. A particularly high level of activity can be observed on the African continent at the moment, as the latest example shows.
Read
Commented by André Will-Laudien on December 22nd, 2022 | 11:18 CET
Christmas hype alert: BASF, Meta Materials, Varta, Nordex - Strong start to 2023 with GreenTech!
Fossil energy supply is becoming more and more expensive. The political end of the supplier and raw material giant Russia creates a dangerous undersupply, especially for Central Europe. The current winter, but especially the next one, could pose problems, and the industry will probably have to calculate significantly higher input costs in the medium term. Products are becoming considerably more expensive to produce, so selling prices on the shelves are also increasing. The inflationary spiral will thus continue to spiral upward, and consumers' purchasing power will decline. GreenTech solutions are more in demand than ever for the purchase of low-cost energy. So which stocks to watch out for?
Read
Commented by Fabian Lorenz on December 21st, 2022 | 08:48 CET
BASF, BioNTech, Cardiol Therapeutics: Stocks for 2023?
Is there a 400% upside potential in 2023? At the end of a challenging 2022 stock market year, we are looking ahead to the new year. Which share is worth buying, and which is better left alone? In the case of BASF, the high dividend yield is one of the attractions. The latest company news shows that the chemical group is also involved in the mega market of electromobility. But the dependence on gas supplies is causing uncertainty, and an analyst has renewed a sell recommendation for BASF shares. BioNTech, on the other hand, is looking good, even if the chart picture has recently clouded over. The development pipeline is full, capacities - especially in Asia - are being expanded, and analysts are also more courageous again. Investors also need a little courage and, above all, patience with Cardiol Therapeutics. They could soon be rewarded. The cash position of the biotech pearl is almost equal to the market capitalization, the main product is already in the Phase 2 pilot study, and analysts see massive upside potential.
Read
Commented by André Will-Laudien on December 21st, 2022 | 08:46 CET
The best cards for 2023: Amazon, Aspermont, flatexDEGIRO, TUI - Which stock will take off?
Crisis, crisis, crisis - we do not want to hear any more about it at Christmas time. After the relief rally, the stock markets have gone back to sleep. It was turbulent until September, and then the correction was over for the time being. But how much "good" is already priced in for next year? Will there be a quick end to the war, can the inflation rate also fall, and what will interest rates do in 2023? Many unanswered questions that will likely only be answered gradually. The shares have to achieve a fair valuation from this mixed situation - perhaps that is why the correction is not quite over yet. Where are the best opportunities for investors?
Read
Commented by Armin Schulz on December 21st, 2022 | 07:14 CET
Kodiak Copper, Volkswagen, Nordex - Copper price rises due to positive news from China!
In mid-July, the copper price marked its low for the year. Since then, a slight upward trend has formed, indicating a robust economy. There are as many as three positive signals for copper. First, there is the weakness of the dollar, which is supporting demand for the red gold. Second, China's announcement that it plans to strengthen its economy after easing Corona measures is providing a boost. If China eases its monetary policy, this would strengthen the real estate sector and fuel the hunger for commodities. Third, M&A activity around copper appears to be increasing. Therefore, we look at three companies in the copper space.
Read